Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIGD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FMNL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00094 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC01096 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CMPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCSK1N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLRP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0232 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FERMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM121 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSFL1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXorf40A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on